Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Share-based Compensation (2023 - 2025)

Upstream Bio has reported Share-based Compensation over the past 3 years, most recently at $2.5 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $2.5 million for Q4 2025, up 20.13% from a year ago — trailing twelve months through Dec 2025 was $10.3 million (up 72.09% YoY), and the annual figure for FY2025 was $10.3 million, up 72.09%.
  • Share-based Compensation for Q4 2025 was $2.5 million at Upstream Bio, down from $2.6 million in the prior quarter.
  • Over the last five years, Share-based Compensation for UPB hit a ceiling of $2.6 million in Q1 2025 and a floor of $643000.0 in Q1 2024.
  • Median Share-based Compensation over the past 3 years was $2.0 million (2024), compared with a mean of $1.8 million.
  • Peak annual rise in Share-based Compensation hit 309.8% in 2025, while the deepest fall reached 20.13% in 2025.
  • Upstream Bio's Share-based Compensation stood at $813000.0 in 2023, then surged by 156.58% to $2.1 million in 2024, then increased by 20.13% to $2.5 million in 2025.
  • The last three reported values for Share-based Compensation were $2.5 million (Q4 2025), $2.6 million (Q3 2025), and $2.6 million (Q2 2025) per Business Quant data.